Literature DB >> 3491497

Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease.

D P Naidich, J J Lee, S M Garay, D I McCauley, C P Aranda, A D Boyd.   

Abstract

CT was compared to fiberoptic bronchoscopy in a large series of patients to study the value of CT for visualizing bronchial disease. CT scans were available for review in 64 cases in which focal airway disease was identified with fiberoptic bronchoscopy and in 38 patients in whom the airways appeared normal at bronchoscopy. CT was positive in 59 of 64 cases in which lesions were detected endoscopically. If the results are analyzed according to the extent of involvement of individual bronchi, CT successfully identified 88 (90%) of 98 lesions. CT correctly excluded disease in 35 (92%) of 38 cases that were subsequently verified to be normal by fiberoptic bronchoscopy. In no case was the diagnosis of malignancy missed by CT. While extremely accurate in detecting focal lesions, CT was inaccurate in predicting whether a given abnormality was endobronchial, submucosal, or extrinsic (peribronchial). In three cases CT failed to detect submucosal extension into the left mainstream bronchus, which has important implications concerning the value of CT in staging bronchial malignancy. It is concluded that CT is helpful when bronchoscopy is contraindicated or refused. CT may also be used in selected cases when there is low clinical suspicion of endobronchial disease and as a complementary procedure to fiberoptic bronchoscopy for outlining the exact location of major mediastinal and hilar vessels, lymph nodes, and tumor in relation to adjacent airways.

Entities:  

Mesh:

Year:  1987        PMID: 3491497     DOI: 10.2214/ajr.148.1.1

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Computed tomography of the airways.

Authors:  S A Worthy; C D Flower
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer.

Authors:  C Laroche; I Fairbairn; H Moss; J Pepke-Zaba; L Sharples; C Flower; R Coulden
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

4.  Diagnostic potential of virtual bronchoscopy: advantages in comparison with axial CT slices, MPR and mIP?

Authors:  U Rapp-Bernhardt; T Welte; W Doehring; S Kropf; T M Bernhardt
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

Review 5.  Pleural effusion.

Authors:  A R Medford; A Medford; N Maskell
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

6.  Computed tomography and bronchoscopy in chest radiographically occult main-stem neoplasm diagnosis and Nd-YAG laser treatment in 8 patients.

Authors:  A F Gelb; D R Aberle; M J Schein; D P Naidich; J D Epstein; D P Tashkin
Journal:  West J Med       Date:  1990-10

7.  Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.

Authors:  Arthur Cho; Jin Hur; Won Jun Kang; Ho Jin Cho; Jae-Hoon Lee; Mijin Yun; Jong Doo Lee
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

8.  Virtual endoscopy of the tracheo-bronchial system: sub-millimeter collimation with the 16-row multidetector scanner.

Authors:  M Fawad Khan; Christopher Herzog; Hanns Ackermann; Thomas O F Wagner; Adel Maataoui; Marc Harth; Nasreddin D Abolmaali; Volkmar Jacobi; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-05-07       Impact factor: 5.315

9.  Prevalence and outcome of central airway obstruction in patients with lung cancer.

Authors:  Cyrus Daneshvar; William Euan Falconer; Mohammed Ahmed; Abdul Sibly; Madeleine Hindle; Thomas W Nicholson; Ghanem Aldik; Lilanganee A Telisinghe; Richard D Riordan; Adrian Marchbank; David Breen
Journal:  BMJ Open Respir Res       Date:  2019-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.